The Bcl-2/Bax ratio of lymphocytes from human systemic lupus erythematosus patients

REFERENCES

• Mountz JD, Wu J, Cheng J et al: Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37: 1415–1420, 1994.
   PubMed Web of Science ®Google Scholar
• Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747–1756, 1989.
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R, Brannan CI, Copeland NG et al: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317, 1992.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tanaka M, Brannan GI et al: Generalized lymphoproliferative disease in mice caused by a point mutation of the Fas ligand. Cell 76: 969–976, 1994.
   PubMed Web of Science ®Google Scholar
• Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152: 3685–3692, 1994.
   PubMed Web of Science ®Google Scholar
• Mysler E, Bini P, Drappa J et al: The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 93: 1029–1034, 1994.
   PubMed Web of Science ®Google Scholar
• Ohsako S, Hara M, Harigai M et al: Expression and function of Fas antigen and Bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 73: 109–114, 1994.
   PubMedGoogle Scholar
• Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6, 1994.
   PubMed Web of Science ®Google Scholar
• Strasser A, Whittingham S, Vaux DL et al: Enforced Bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88: 8661–8665, 1991.
   PubMed Web of Science ®Google Scholar
• Aringer M, Wintersberger W, Steiner CW et al: High levels of Bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 37: 1423–1430, 1994.
   PubMed Web of Science ®Google Scholar
• William GT, Smith CA: Molecular regulation of apoptosis. Cell 74: 777–779, 1993.
   PubMed Web of Science ®Google Scholar
• Lin EY, Orlofsky A, Berger MS et al: Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity of Bcl-2. J Immunol 151: 1979–1988, 1993.
   PubMed Web of Science ®Google Scholar
• Boice LH, Gonzales-Garcia M, Postema CE et al: bcl-X, a 6c/-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597–608, 1993.
   Google Scholar
• Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609–619, 1993.
   PubMed Web of Science ®Google Scholar
• Kozopas KM, Yang T, Bucham HL et al: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc Natl Acad Sci USA 90: 3516–3520, 1993.
   PubMed Web of Science ®Google Scholar
• Tin X-M, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321–323, 1994.
   Google Scholar
• Korsmeyer SJ, Shutter JR, Veis DJ et al: Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327–332, 1993.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982.
   Google Scholar
• Urowitz MB, Gl adman DD, Tozman ECS et al: The lupus activity criteria count (LACC). J Rheumatol 11: 783–787, 1984.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB et al: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630–640, 1992.
   PubMed Web of Science ®Google Scholar
• Guzman J, Cardiel MH, Arce-Salinas A et al: Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 19: 1551–1558, 1992.
   PubMed Web of Science ®Google Scholar
• Krajewski S, Krajewska M, Shabaik A et al: Irnmunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145: 1323–1336, 1994.
   PubMed Web of Science ®Google Scholar
• Niinez G, Merino R, Grillot D et al: Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 15: 582–588, 1994.
   Google Scholar
• Yang E, Zha J, Jockel J et al: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285–291, 1995.
   PubMed Web of Science ®Google Scholar
• Farrow SN, White JHM, Martinou I et al: Cloning of a Bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374: 731–733, 1995.
   PubMed Web of Science ®Google Scholar
• Chittenden T, Harrington EA, O’Connor R et al: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733, 1995.
   PubMed Web of Science ®Google Scholar
• Kiefer MC, Brauer MJ, Powers VC et al: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736–739, 1995.
   PubMed Web of Science ®Google Scholar
• Sato T, Hanada M, Bodrug S et al.: Interaction among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91: 9238–9242, 1994.
   PubMed Web of Science ®Google Scholar
• Bargou RC, Daniel PT, Mapara MY et al: Expression of the Bcl-2 gene family in normal and malignant breast tissue: low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60: 854–859, 1995.
   PubMed Web of Science ®Google Scholar
• Yuan J, Shaham S, Ledoux S et al: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-lb-converting enzyme. Cell 75: 641–652, 1993.
   PubMed Web of Science ®Google Scholar
• Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78–81, 1995.
   PubMed Web of Science ®Google Scholar
• Los M, Van de Craen M, Penning LC et al: Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature 375: 81–83, 1995.
   PubMed Web of Science ®Google Scholar
• Hermann S: Mechanisms and genes of cellular suicide. Science 267: 1445–1449, 1995.
   PubMed Web of Science ®Google Scholar
• Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462, 1995.
   PubMed Web of Science ®Google Scholar
• Ohta K, Iwai K, Kasahara Y et al: Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int Immunol 7: 1817–1825, 1995.
   PubMed Web of Science ®Google Scholar
• Radvanyi LG, Shi Y, Vaziri H et al: CD28 costimulation inhibits TCR-induced apoptosi during a primary T cell response. J Immunol 156: 1788–1798, 1996.
   PubMed Web of Science ®Google Scholar
• Boise LH, Minn AJ, Noel PJ et al: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87–98, 1995.
   PubMed Web of Science ®Google Scholar
• Hara M, Kitani A, Harigai M et al: Difference abnormality in cell-cycle stage peripheral B cells from patients with systemic lupus erythematosus. Rheumatol Int 7: 83–87, 1987.
   Google Scholar
• Tsubata T, Wu J, Honjo T: B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364: 645–648, 1993.
   PubMed Web of Science ®Google Scholar
• Mountz JD, Zhou T, Wu J et al: Regulation of apoptosis in immune cells. J Clin Immunol 15: 1–16, 1995.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Oglesby R, Sfikakis P et al: B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 96: 8–14, 1994.
   Google Scholar
• Alvarado C, Alcocer-Varela J, Lorente L et al,: Effect of CD28 autoantibody on T cells from systemic lupus erythematosus. J Autoimmun 7: 763–773, 1994.
   PubMedGoogle Scholar